| Jul 16 |
New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the “Lipid Lurkers” Inside Their Arteries
|
| Jun 29 |
Notable analyst calls this week: Nike, Micron and FedEx among top picks
|
| Jun 28 |
PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
|
| Jun 28 |
Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility
|
| Jun 20 |
Esperion closes down 16% following BofA downgrade
|
| Jun 20 |
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
| Jun 17 |
Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?
|
| Jun 13 |
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
|
| Jun 11 |
3 Penny Stocks to Buy if You Want to Spend Less and Earn More
|
| Jun 7 |
Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?
|
